PEOPLE - Sanguine makes appointment:
This article was originally published in Clinica
Executive Summary
Sanguine (Pasadena, California), a developer of synthetic substitutes for red blood cells, has appointed Joseph O'Malley to the position of blood therapy medical consultant. Sanguine is about to embark on FDA toxicity studies of its PHER-O2 blood cell substitute.